Real time monitoring of the cell viability during treatment with tumor-targeted toxins and saponins using impedance measurement

Biosensors and Bioelectronics

Volumn 35, Issue 1, 2012, Pages 503-506

  Thakur, Mayank ^a   Mergel, Katharina ^a   Weng, Alexander ^a   Frech, Stefanie ^c   Gilabert Oriol, Roger ^a   Bachran, Diana ^a   Melzig, Matthias F ^b   Fuchs, Hendrik ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Bionas GmbH   (Germany)

Author keywords

Impedance measurement; Real time cell viability; Ribosome inactivating proteins; Saponins; Targeted toxins; Tumor treatment

Indexed keywords

CELL VIABILITY; IMPEDANCE MEASUREMENT; RIBOSOME-INACTIVATING PROTEIN; SAPONINS; TARGETED TOXINS; TUMOR TREATMENT;

CELL CULTURE; CELL DEATH; ELECTRIC IMPEDANCE MEASUREMENT; SUGARS; TOXICITY; TUMORS;

METABOLITES;

SAPONIN; TOXIN;

ARTICLE; CELL COUNT; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOXICITY; HELA CELL; HUMAN; HUMAN CELL; IMPEDANCE; MEASUREMENT; MONITORING; PROCESS OPTIMIZATION; TARGET CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; BIOSENSING TECHNIQUES; CELL SURVIVAL; COMPUTER SYSTEMS; DRUG SYNERGISM; ELECTRIC IMPEDANCE; HELA CELLS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SAPONINS; TOXINS, BIOLOGICAL;

MUS; SAPONARIA OFFICINALIS;

EID: 84860507956     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2012.03.024     Document Type: Article

References (15)

1. Arias M., Quijano J.C., Haridas V., Gutterman J.U., Lemeshko V.V. Biochim. Biophys. Acta 2011, 1798(6):1189-1196.
2. Armour A.D., Powell H.M., Boyce S.T. Tissue Eng. C: Methods 2008, 14(1):89-96.
3. Bachran C., Durkop H., Sutherland M., Bachran D., Muller C., Weng A., Melzig M.F., Fuchs H. J. Immunother. 2009, 32(7):713-725.
4. Bachran D., Schneider S., Bachran C., Urban R., Weng A., Melzig M.F., Hoffmann C., Kaufmann A.M., Fuchs H. Int. J. Cancer 2010, 127(6):1453-1461.
5. Campbell C.E., Laane M.M., Haugarvoll E., Giaever I. Biosens. Bioelectron. 2007, 23(4):536-542.
6. Ehret R., Baumann W., Brischwein M., Schwinde A., Stegbauer K., Wolf B. Biosens. Bioelectron. 1997, 12(1):29-41.
7. Ehret R., Baumann W., Brischwein M., Schwinde A., Wolf B. Med. Biol. Eng. Comput. 1998, 36(3):365-370.
8. Fuchs H., Bachran D., Panjideh H., Schellmann N., Weng A., Melzig M.F., Sutherland M., Bachran C. Curr. Drug Targets 2009, 10(2):140-151.
9. Malleo D., Nevill J.T., Lee L.P., Morgen H. Microfluid. Nanofluid. 2009, 9(2-3):191-198.
10. Mosmann T. J. Immunol. Methods 1983, 65(1-2):55-63.
11. Qiu Y., Liao R., Zhang X. Biophys. J. 2009, 96(5):1985-1991.
12. Soory M. Infect. Disord. Drug Targets 2009, 9(4):400-414.
13. Thakur M., Melzig M.F., Fuchs H., Weng A. Botanics: Targets Ther. 2011, 2011:19-29.
14. Thakur M., Weng A., Bachran D., Riese S.B., Bottger S., Melzig M.F., Fuchs H. Electrophoresis 2011, 32(21):3085-3089.
15. Weng, A., Thakur, M., Becren-Braun, F., Bachran, D., Bachran, C., Riese, S.B., Jenett-Siems, K., Gilabert-Oriol, R., Melzig, M.F., Fuchs, 2012. H. Mol. Oncol., in press. doi:10.1016/j.molonc.2012.01.004.